n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
about
Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literatureFADS genetic variants and omega-6 polyunsaturated fatty acid metabolism in a homogeneous island populationWhat is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trialsAn Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for ObesityVascular repair strategies in type 2 diabetes: novel insights(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsPreservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese miceUnmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat dietMetabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoidsHepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid compositionFatty fish intake decreases lipids related to inflammation and insulin signaling--a lipidomics approach.Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.Detailed distribution of lipids in Greenshell™ mussel (Perna canaliculus).Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in miceAssociations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosPurification of Alaskan walleye pollock (Gadus chalcogrammus) and New Zealand hoki (Macruronus novaezelandiae) liver oil using short path distillationEffect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus PatientsMPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile.Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study.Association of an ACSL1 gene variant with polyunsaturated fatty acids in bovine skeletal muscle.Corporate externalities: a challenge to the further success of prevention scienceAMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.Biological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial.Nutritional strategies in the prevention and treatment of metabolic syndrome.Are functional foods redefining nutritional requirements?The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population.Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acidsInvolvement of gut microbial fermentation in the metabolic alterations occurring in n-3 polyunsaturated fatty acids-depleted mice.Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management.Resolvins and protectins in inflammation resolution.The relationship between dietary habits, blood glucose and insulin levels among people without cardiovascular disease and type 2 diabetes; the ATTICA studyOmega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.The Effect of Krill Oil Supplementation on Exercise Performance and Markers of Immune Function.Omega 3 Fatty Acids Supplementation and Oxidative Stress in HIV-Seropositive Patients. A Clinical Trial.Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial.Effects of flaxseed oil on anti-oxidative system and membrane deformation of human peripheral blood erythrocytes in high glucose level.Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects.Mediation of cognitive function by high fat diet following stress and inflammation.Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial.
P2860
Q24619357-0F55C2BE-C7A0-4520-9BD4-0F0E15282CBCQ24634017-7FEFDE02-E59B-40A2-8819-39D8571B1BB1Q26740239-E4587FEE-1AE5-412B-BA05-FFBFC1C93E07Q26767356-764A387B-E81C-4CA7-92E4-3BAB7E4F262DQ26778658-627577D0-632D-4AA3-98ED-A548579433B9Q27013554-9251C2D0-B899-4864-B10F-8849555247BCQ27322378-5B3ED38B-1102-4E01-A88B-B1C595A0A2DAQ28477781-0D1F9FBC-1787-43A4-81C3-C2180AF2DCD7Q28728625-5E2E8B19-82CB-4682-8977-843C8BD841EFQ33388523-051625BE-AA1A-45BB-8ED7-DD7C108486B2Q33434417-E9372AD9-6D4C-44C9-A1E4-95B091A26590Q33564624-57B48CDB-8A25-4119-8C23-90F41FCAEA8EQ33570415-A9E088E4-7EAE-47BD-8ED3-7435FC76444FQ33631964-722DFFB1-1A10-4662-842D-7947260AE3C8Q33666208-914ABD88-A218-43B5-B855-619810ECCFF2Q33702706-6C246718-37AF-446F-B428-02B89F019C4FQ33851933-8D9A6CBE-F3FB-45CD-9A22-4B771C4D78B7Q33892898-092E2693-6BA2-4703-82E5-3D97A89AB981Q34013676-E2EC7BBA-19F3-492B-936B-65022609A9D6Q34073184-05ECB41B-1C20-4E76-A400-E032D26BDAF2Q34158541-4B617376-C289-49ED-88D5-FC2E51644D23Q34237595-4F28D9B4-A4A8-4377-B207-ED6ACF77D507Q34499654-C230E911-1703-45B2-909D-AF4AF3FBAA15Q34576718-55103A30-EEB8-4776-811C-A6C3591D977AQ34762534-691154B7-7EB8-42B6-9BFB-10FA5DB1C365Q34915433-9D8C1BF4-4309-448B-BF68-34FC0CB332D9Q35068782-04EF60D2-B898-4ED6-A423-375345BE0772Q35121251-507C264F-797E-4449-99C3-AEEA56791955Q35235688-67478007-336A-421F-B061-A7225F9246D9Q35252642-876FFB94-4BFF-4E16-A75F-16350ACCE3ECQ35332873-2B76076C-285A-457F-8801-AD12E8F2CA89Q35612710-9AF28EB2-318F-4B84-83E1-AB4B8C68A301Q35633941-3233D691-A4C5-46C2-81D1-FB43C1979292Q35788498-1EA96324-CA25-45CB-B8BB-D2D5FE37F09CQ35970578-B47F4F33-3513-49F0-83AB-CF82ED5DE954Q36197756-A19F2BD8-4720-4DC1-9418-4431D0BDF282Q36284084-4EAB3577-2E7A-4A6E-A96D-9A2CAFA9EA96Q36423040-850C6A56-A12A-4F69-A382-4BA936E6D705Q36466438-F91C75BA-1044-47CA-B6BD-F3E514586CE8Q36564507-281AA8C5-7062-4AD1-966D-EA752AC63060
P2860
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@ast
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@en
type
label
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@ast
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@en
prefLabel
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@ast
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@en
P1476
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
@en
P2093
Joyce A Nettleton
Robert Katz
P304
P356
10.1016/J.JADA.2004.11.029
P577
2005-03-01T00:00:00Z